Cargando…

What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors

In India, an unexplained enteropathy is present in a majority of non-cirrhotic intrahepatic portal hypertension (NCIPH) patients. Small intestinal bacterial contamination and tropical enteropathy could trigger inflammatory stimuli and activate the endothelium in the portal venous system. Groundwater...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goel, Ashish, Ramakrishna, Banumathi, Zachariah, Uday, Sajith, K.G., Burad, Deepak K., Kodiatte, Thomas A., Keshava, Shyamkumar N., Balasubramanian, K.A., Elias, Elwyn, Eapen, C.E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676844/ https://www.ncbi.nlm.nih.gov/pubmed/31411170 http://dx.doi.org/10.4103/ijmr.IJMR_1405_17

Ejemplares similares

A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India
por: Goel, Ashish, et al.
Publicado: (2013)

Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification
por: Burad, Deepak Kalyansingh, et al.
Publicado: (2016)

Analyzing lipids in the liver & in the red blood cell membrane in liver diseases
por: Eapen, C.E., et al.
Publicado: (2018)

Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance
por: Keshava, Shyamkumar N., et al.
Publicado: (2021)

Measurement of hepatic venous pressure gradient revisited: Catheter wedge vs balloon wedge techniques
por: Chelliah, S Timothy, et al.
Publicado: (2011)

Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid
por: Zachariah, U., et al.
Publicado: (2020)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Management of Portal Vein Thrombosis in Cirrhotic Patients
por: Amitrano, Lucio, et al.
Publicado: (2009)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Metastases can occur in cirrhotic livers with patent portal veins
por: Mahdi, Zaid, et al.
Publicado: (2021)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Non-cirrhotic portal vein thrombosis – therapeutic challenge
por: Sarquis, Lucas Mansano, et al.
Publicado: (2022)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats
por: Tripathi, Dinesh Mani, et al.
Publicado: (2020)

Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension
por: Kmeid, Michel, et al.
Publicado: (2020)

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
por: Gîrleanu, Irina, et al.
Publicado: (2018)

A rare newly described overgrowth syndrome with vascular malformations-Cloves syndrome
por: Gopal, Balaji, et al.
Publicado: (2015)

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
por: Cunningham, Morven E., et al.
Publicado: (2019)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome
por: Karthikumar, Balasubramanian, et al.
Publicado: (2018)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow
por: Jayakumar Amirtharaj, G., et al.
Publicado: (2014)

Contrast-enhanced Computed Tomography Imaging of Splenic Artery Aneurysms and Pseudoaneurysms: A Single-center Experience
por: Therakathu, Jacob, et al.
Publicado: (2018)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats
por: Gunarathne, Lakmie S., et al.
Publicado: (2019)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
por: Artru, Florent, et al.
Publicado: (2022)

Association Between Portal Vein Color Doppler Findings and the Severity of Disease in Cirrhotic Patients With Portal Hypertension
por: Mittal, Puneet, et al.
Publicado: (2011)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Is There an Association between Variceal Bleed and Helicobacter pylori Infection in Cirrhotic Patients with Portal Hypertension?: A prospective cohort study
por: Varuna, Sathyanarayan, et al.
Publicado: (2022)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9pvr1j751jvdn7qgrd028osdtj